{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:01:08Z","timestamp":1795024868665,"version":"4.10.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT118514"],"award-info":[{"award-number":["GNT118514"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2025266"],"award-info":[{"award-number":["GNT2025266"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["FLF105666"],"award-info":[{"award-number":["FLF105666"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Megadose sodium ascorbate has shown promise as a treatment to reverse the pathophysiological effects of ovine Gram-negative sepsis. In human septic shock, lower doses of sodium ascorbate improved urine output and reduced vasopressor requirements compared with placebo. We sought to determine the minimum therapeutic dose of sodium ascorbate required to reverse sepsis-induced cardiovascular and renal dysfunction in sheep.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Healthy young adult sheep were instrumented with renal artery flow probes, and oxygen-sensing and laser Doppler probes in the kidneys. Non-anaesthetised animals were infused with live\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      for 31-h. At 23.5-h of sepsis, four groups (n\u2009=\u20097\u20138\/group) received fluid resuscitation (30\u00a0mL\/kg Hartmann\u2019s solution) and were randomized to intravenous sodium ascorbate (1.0, 2.0, or 3.0\u00a0g\/kg) or vehicle, delivered as a bolus followed by 7-h infusion. Norepinephrine was titrated to maintain mean arterial pressure (MAP) at\u2009~\u200970\u00a0mmHg.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 23-h of sepsis, animals developed hypotension, hyperlactatemia, acute kidney injury, and renal medullary hypoxia. Vehicle-treated sheep required escalating doses of norepinephrine (from 0.4 to 0.8\u2009\u00b1\u20090.2\u00a0\u00b5g\/kg\/min) to restore MAP. Sodium ascorbate at 3.0\u00a0g\/kg (achieving plasma ascorbate levels of\u2009~\u200910\u00a0mmol\/L) rapidly restored MAP, allowing withdrawal of norepinephrine in half the animals (P\u2009=\u20090.007). Lower doses of sodium ascorbate (1.0 and 2.0\u00a0g\/kg) had no significant effect on vasopressor requirements. The improvements in renal medullary oxygenation (25.2\u2009\u00b1\u20093.3 to 43.4\u2009\u00b1\u20094.5\u00a0mmHg, P\u2009=\u20090.04) and urine flow (from 0.5\u2009\u00b1\u20090.2 to 6.9\u2009\u00b1\u20092.4\u00a0ml\/kg\/h, P\u2009&lt;\u20090.0001) were dose-dependent. Renal medullary tissue protein expression of nuclear factor kappa-light chain-enhancer B was significantly reduced with 3.0\u00a0g\/kg of sodium ascorbate (to -52.9\u2009\u00b1\u200913.3%, P\u2009=\u20090.0005) and phosphorylated endothelial nitric oxide synthase at Ser-1177 was upregulated (to +219.5\u2009\u00b1\u200951.4%, P\u2009=\u20090.04) compared with vehicle-treated sheep.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In established ovine Gram-negative sepsis, only 3.0\u00a0g\/kg sodium ascorbate effectively restored cardiovascular and renal dysfunction, which was associated with suppression of renal inflammatory signalling and restoration of endothelial nitric oxide activity. These findings demonstrate a clear dose-dependent therapeutic threshold, where achieving plasma ascorbate concentrations of\u2009~\u200910\u00a0mmol\/L is essential to elicit multi-organ protection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-025-05799-5","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T08:34:30Z","timestamp":1766910870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A preclinical randomised controlled dose optimization of megadose sodium ascorbate for reversal of gram-negative sepsis-induced cardiovascular, brain and kidney dysfunction"],"prefix":"10.1186","volume":"30","author":[{"given":"Connie Pei Chen","family":"Ow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Trask-Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally G.","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashenafi H.","family":"Betrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius J. R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive N.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugeesh R.","family":"Lankadeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"issue":"10219","key":"5799_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"8","key":"5799_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11081580","volume":"11","author":"T Sinnberg","year":"2022","unstructured":"Sinnberg T, Lichtensteiger C, Hill-Mundel K, Leischner C, Niessner H, Busch C, et al. Vitamin C deficiency in blood samples of COVID-19 patients. Antioxidants. 2022;11(8):1580.","journal-title":"Antioxidants"},{"issue":"3","key":"5799_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00003246-199603000-00006","volume":"24","author":"E Borrelli","year":"1996","unstructured":"Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, Dayer J, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996;24(3):392\u20137.","journal-title":"Crit Care Med"},{"issue":"11","key":"5799_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/nu9111211","volume":"9","author":"AC Carr","year":"2017","unstructured":"Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211.","journal-title":"Nutrients"},{"key":"5799_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s13054-015-1131-2","volume":"19","author":"AC Carr","year":"2015","unstructured":"Carr AC, Shaw GM, Fowlerm AA, Natarajan R. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care. 2015;19:418.","journal-title":"Crit Care"},{"issue":"17","key":"5799_CR6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1089\/ars.2013.5401","volume":"19","author":"JX Wilson","year":"2013","unstructured":"Wilson JX. Evaluation of vitamin C for adjuvant sepsis therapy. Antioxid Redox Signal. 2013;19(17):2129\u201340.","journal-title":"Antioxid Redox Signal"},{"key":"5799_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1479-5876-12-32","volume":"12","author":"AA Fowler III","year":"2014","unstructured":"Fowler AA III, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.","journal-title":"J Transl Med"},{"issue":"5","key":"5799_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2019.22176","volume":"323","author":"T Fujii","year":"2020","unstructured":"Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock. JAMA. 2020;323(5):423\u201331.","journal-title":"JAMA"},{"issue":"1","key":"5799_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13054-025-05383-x","volume":"29","author":"S Vandervelden","year":"2025","unstructured":"Vandervelden S, Cortens B, Fieuws S, Eegdeman W, Malinverni S, Vanhove P, et al. Early administration of vitamin C in patients with sepsis or septic shock in emergency departments: a multicenter, double-blind, randomized controlled trial: the C-EASIE trial. Crit Care. 2025;29(1):160.","journal-title":"Crit Care"},{"issue":"1","key":"5799_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13054-022-03891-8","volume":"26","author":"J-R Lavillegrand","year":"2022","unstructured":"Lavillegrand J-R, Raia L, Urbina T, Hariri G, Gabarre P, Bonny V, et al. Vitamin C improves microvascular reactivity and peripheral tissue perfusion in septic shock patients. Crit Care. 2022;26(1):25.","journal-title":"Crit Care"},{"issue":"13","key":"5799_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"AA Fowler III","year":"2019","unstructured":"Fowler AA III, Truwit JD, Hite RD, Morris PE, DeWilder, Priday A, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. JAMA. 2019;322(13):1261\u201370.","journal-title":"JAMA."},{"issue":"1","key":"5799_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13054-021-03872-3","volume":"26","author":"SY Jung","year":"2022","unstructured":"Jung SY, Lee MT, Baek MS, Kim WY. Vitamin C for \u2265 5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study. Crit Care. 2022;26(1):3.","journal-title":"Crit Care"},{"issue":"18","key":"5799_CR13","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/jama.2023.21407","volume":"330","author":"LOVIT-COVID Investigators obotCCCTG, and the REMAP-CAP Investigators","year":"2023","unstructured":"LOVIT-COVID Investigators obotCCCTG, and the REMAP-CAP Investigators. Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials. JAMA. 2023;330(18):1745\u201359.","journal-title":"JAMA"},{"key":"5799_CR14","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","volume":"386","author":"F Lamontagne","year":"2022","unstructured":"Lamontagne F, Masse M-H, Sprague MS, Pinto R, Heyland DK, Cook DJ, et al. Intravenous vitamin C in adults with sepsis in the intensive care unit. N Engl J Med. 2022;386:2387\u201398.","journal-title":"N Engl J Med"},{"issue":"2","key":"5799_CR15","first-page":"63","volume":"25","author":"YR Lankadeva","year":"2023","unstructured":"Lankadeva YR, Lane DJR, Ow CPC, Story DA, Plummer MP, May CN. LOVIT or leave it: the vitamin C debate continues. Crit Care Resusc. 2023;25(2):63\u20134.","journal-title":"Crit Care Resusc"},{"issue":"3","key":"5799_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1399-6576.1974.tb00864.x","volume":"18","author":"EJ Crul-Sluijter","year":"1974","unstructured":"Crul-Sluijter EJ, Crul JF. Acidosis and neuromuscular blockade. Acta Anaesthesiol Scand. 1974;18(3):224\u201336.","journal-title":"Acta Anaesthesiol Scand"},{"key":"5799_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejim.2020.02.027","volume":"76","author":"B Wernly","year":"2020","unstructured":"Wernly B, Heramvand N, Masyuk M, Rezar R, Bruno RR, Kelm M, et al. Acidosis predicts mortality independently from hyperlactatemia in patients with sepsis. Eur J Intern Med. 2020;76:76\u201381.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"5799_CR18","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1097\/CCM.0000000000004770","volume":"49","author":"YR Lankadeva","year":"2021","unstructured":"Lankadeva YR, Peiris RM, Okazaki N, Birchall IE, Trask-Marino A, Dornom A, et al. Reversal of the pathophysiological responses to Gram-negative sepsis by megadose vitamin C. Crit Care Med. 2021;49(2):e179\u201390.","journal-title":"Crit Care Med"},{"issue":"2","key":"5799_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bja.2024.04.058","volume":"133","author":"CN May","year":"2024","unstructured":"May CN, Ow CPC, Pustovit RV, Lane DJR, Jufar AH, Trask-Marino A, et al. Reversal of cerebral ischaemia and hypoxia and of sickness behaviour by megadose sodium ascorbate in ovine Gram-negative sepsis. Br J Anaesth. 2024;133(2):316\u201325.","journal-title":"Br J Anaesth"},{"issue":"1","key":"5799_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13054-023-04644-x","volume":"27","author":"F Yanase","year":"2023","unstructured":"Yanase F, Spano S, Maeda A, Chaba A, Naorungroj T, Ow CPC, et al. Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial. Crit Care. 2023;27(1):371.","journal-title":"Crit Care"},{"issue":"7","key":"5799_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N du Percie Sert","year":"2020","unstructured":"du Percie Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410.","journal-title":"PLoS Biol"},{"key":"5799_CR22","doi-asserted-by":"crossref","unstructured":"Lankadeva YR, Kosaka J, Evans RG, May CN. An ovine model for studying the pathophysiology of septic acute kidney injury. In: Tharakan B, editor. Methods Mol Biol. Traumatic and Ischemic Injuries: Methods and Protocols. 17172018. p. 207\u201318.","DOI":"10.1007\/978-1-4939-7526-6_16"},{"issue":"10","key":"5799_CR23","doi-asserted-by":"publisher","first-page":"R832","DOI":"10.1152\/ajpregu.00515.2014","volume":"308","author":"P Calzavacca","year":"2015","unstructured":"Calzavacca P, Evans RG, Bailey M, Lankadeva YR, Bellomo R, May CN. Long-term measurement of renal cortical and medullary tissue oxygenation and perfusion in unanesthetized sheep. Am J Physiol Regul Integr Comp Physiol. 2015;308(10):R832-9.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5799_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14025","volume":"239","author":"AH Betrie","year":"2023","unstructured":"Betrie AH, Ma S, Ow CPC, Peiris RM, Evans RG, Ayton S, et al. Renal arterial infusion of tempol prevents medullary hypoperfusion, hypoxia, and acute kidney injury in ovine Gram-negative sepsis. Acta Physiol. 2023;239:e14025.","journal-title":"Acta Physiol"},{"key":"5799_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/cvr\/28.3.303","volume":"28","author":"J Ludbrook","year":"1994","unstructured":"Ludbrook J. Repeated measures and multiple comparisons in cardiovascular research. Cardiovasc Res. 1994;28:303\u201311.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"5799_CR26","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. Kdigo clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384.","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"5799_CR27","first-page":"236","volume":"21","author":"EP Hudson","year":"2019","unstructured":"Hudson EP, Collie JT, Fujii T, Luethi N, Udy AA, Doherty S, et al. Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock. Crit Care Resusc. 2019;21(4):236\u201342.","journal-title":"Crit Care Resusc"},{"issue":"6","key":"5799_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.semnephrol.2019.10.004","volume":"39","author":"YR Lankadeva","year":"2019","unstructured":"Lankadeva YR, Okazaki N, Evans RG, Bellomo R, May CN. Renal medullary hypoxia: a new therapeutic target for septic acute kidney injury? Semin Nephrol. 2019;39(6):543\u201353.","journal-title":"Semin Nephrol"},{"issue":"1","key":"5799_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.kint.2016.02.017","volume":"90","author":"YR Lankadeva","year":"2016","unstructured":"Lankadeva YR, Kosaka J, Evans RG, Bailey SR, Bellomo R, May CN. Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury. Kidney Int. 2016;90(1):100\u20138.","journal-title":"Kidney Int"},{"issue":"4","key":"5799_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/bja\/50.4.317","volume":"50","author":"RD Miller","year":"1978","unstructured":"Miller RD, Roderick LL. Acid-base balance and neostigmine antagonism of pancuronium neuromuscular blockade. Br J Anaesth. 1978;50(4):317\u201324.","journal-title":"Br J Anaesth"},{"issue":"9","key":"5799_CR31","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.RES.0000187447.03525.72","volume":"97","author":"JK Bendall","year":"2005","unstructured":"Bendall JK, Alp NJ, Warricj N, Cai S, Adlam D, Rockett K, et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res. 2005;97(9):864\u201371.","journal-title":"Circ Res"},{"issue":"11","key":"5799_CR32","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1161\/hh1101.092677","volume":"88","author":"I Fleming","year":"2001","unstructured":"Fleming I, Fissthaler B, Dimmeler S, Kemp BE, Russe R. Phosphorylation of Thr(495) regulates Ca(2+)\/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res. 2001;88(11):E68-75.","journal-title":"Circ Res"},{"issue":"17","key":"5799_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173798","volume":"10","author":"CPC Ow","year":"2021","unstructured":"Ow CPC, Trask-Marino A, Betrie AH, Evans RG, May CN, Lankadeva YR. Targeting oxidative stress in septic acute kidney injury: from theory to practice. J Clin Med. 2021;10(17):3798.","journal-title":"J Clin Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05799-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05799-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05799-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:52:55Z","timestamp":1767635575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-025-05799-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5799"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05799-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Animal Ethics Committee of the Florey Institute of Neuroscience and Mental Health (AEC 20\u2013041).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0"}},{"value":"Lankadeva YR, May CN and Bellomo R are co-inventors on a patent for the use of mega-dose sodium ascorbate in the treatment of sepsis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}